For the first time, a new study has identified enlarged perivascular spaces in the brains of migraine sufferers. Results of the study were presented recently at the annual meeting of the Radiological Society of North America (RSNA).

“In people with chronic migraine and episodic migraine without aura, there are significant changes in the perivascular spaces of a brain region called the centrum semiovale,” said study co-author Wilson Xu, an M.D. candidate at Keck School of Medicine of the University of Southern California in Los Angeles. “These changes have never been reported before.”

Migraine is a common, often debilitating condition, involving a severe recurring headache. Migraines may also cause nausea, weakness, and light sensitivity. According to the American Migraine Foundation, over 37 million people in the U.S. are affected by migraine, and up to 148 million people worldwide suffer from chronic migraine.

The proteins can record histories of cellular events.

Researchers from MIT developed a technique to induce cells to record the history of cellular events in a long protein chain that can be imaged using a light microscope. The technique could help understand the critical steps involved in the processes, such as memory formation, response to drug treatment, and gene expression.

Studying the molecular processes within cells can provide important insights into their function and how they contribute to the overall functioning of an organ.

---

Design Cells/iStock.

“Biological systems are often composed of a large number of different types of cells. To understand those kinds of biological systems, we need to observe physiological events over time in these large cell populations,” said Changyang Linghu, Assistant Professor at the Michigan Neuroscience Institute and author of the study.

Adenosine, a neurotransmitter, has been found to act as a brake on dopamine, another neurotransmitter involved in motor control, by researchers at Oregon Health & Science University. The findings, which were published in the journal Nature, reveal that adenosine and dopamine operate in a push-pull dynamic in the brain.

“There are two neuronal circuits: one that helps promote action and the other that inhibits action,” said senior author Haining Zhong, Ph.D., a scientist with the OHSU Vollum Institute. “Dopamine promotes the first circuit to enable movement, and adenosine is the ‘brake’ that promotes the second circuit and brings balance to the system.”

The discovery has the potential to immediately suggest new avenues for drug development to treat the symptoms of Parkinson’s disease is a movement disorder that is believed to be caused by the loss of dopamine-producing cells in the brain.

Psychedelic drugs were a hot topic at this year’s Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.